Ann Partridge MD MPH

Oncology•Boston, MA

Breast Cancer, Hematologic Oncology

Professor of Medicine, Harvard Medical School; Vice Chair of Medical Oncology, Dana-Farber Cancer Institute

Join to View Full Profile

Dana-Farber Cancer Institute450 Brookline AveBoston, MA 02215
Phone+1 617-632-3800
Fax+1 617-632-1930

Education & Training

Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1998 - 2001
University of Pennsylvania Health SystemResidency, Internal Medicine, 1995 - 1998
Weill Cornell MedicineClass of 1995

Certifications & Licensure

MA State Medical License 1998 - 2026
PA State Medical License 1996 - 1998
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Super Doctor SuperDoctors.com

Clinical Trials

S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer Start of enrollment: 2003 Oct 01
Completed
Phase 3
Extended Endocrine Therapy for Premenopausal Women With Breast Cancer Start of enrollment: 2009 May 01
Completed
Phase 2
The Young Women's Breast Cancer Study
ACTIVE_NOT_RECRUITING
Pilot Study for Young Women's Intervention Start of enrollment: 2011 Mar 01
Completed
Not Applicable
Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer Start of enrollment: 2012 Jun 01
Completed
Not Applicable
Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors Start of enrollment: 2015 Aug 03
Completed
Not Applicable
Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness) Start of enrollment: 2017 Feb 20
Active, not recruiting
Not Applicable
PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions Start of enrollment: 2017 Dec 01
ACTIVE_NOT_RECRUITING
NA
Young, Empowered & Strong (YES): The Young Women's Breast Cancer Study 2- Focus on Intervention Pilot Start of enrollment: 2019 May 23
COMPLETED
NA
YES Study - Newly Diagnosed/Metastatic Intervention Start of enrollment: 2020 Sep 16
RECRUITING
NA
Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study Start of enrollment: 2022 Oct 23
ACTIVE_NOT_RECRUITING
NA
Join now to see all

Publications & Presentations

PubMed

The association between young age at metastatic breast cancer diagnosis and overall survival in the EMBRACE study.
Kristen D Brantley, Gregory J Kirkner, Melissa E Hughes, Leticia Varella, Georgia Suggs
NPJ Breast Cancer. 2025-08-29
ASO Visual Abstract: Patient-Reported Outcomes After Routine Treatment of In-Situ/Atypical Lesions: The PORTAL Study.
Shoshana M Rosenberg, Christel Rushing, Kristin L Schreiber, Kerri-Anne Crowell, Isabelle Bedrosian
Annals of Surgical Oncology. 2025-08-25
Impact of a Weight Loss Intervention on 1-Year Weight Change in Women With Stage II/III Breast Cancer: Secondary Analysis of the Breast Cancer Weight Loss (BWEL) Trial.
Jennifer A Ligibel, Karla V Ballman, Linda McCall, Pamela J Goodwin, Catherine M Alfano
JAMA Oncology. 2025-08-21

Journal Articles

Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-Term Counseling and Medication Advice on Smoking Abstinence in Patients Recentl...
Jennifer S Temel, Ann H Partridge, JAMA
Effect of Eribulin with or Without Pembrolizumab on Progression-Free Survival for Patients with Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer
Sara M Tolaney, Gerburg Wulf, Laura Spring, Beth Overmoyer, Ann H Partridge, Eric P Winer, Ian E Krop, JAMA Oncology

Lectures

POSITIVE (IBCSG 48-14/BIG 8-13/A221405): Evaluating outcomes after interrupting endocrine therapy (ET) for women with endocrine responsive (ER+) early breast cancer (B...
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Other

Approach to the long-term survivor of breast cancer
Partridge AH, Ruddy KJ
http://www.uptodate.com/contents/approach-to-the-long-term-survivor-of-breast-cancer
UpToDate, Wolters Kluwer Health - 2013-03-29

Press Mentions

Metastatic Breast Cancer Highlights from ASCO 2025June 24th, 2025
Non-Hormonal Drug Reduced Hot Flashes from Endocrine Therapy for Breast CancerJune 3rd, 2025
Breast Cancer Mortality in Younger Women Plummets over DecadeMay 8th, 2025
Join now to see all